Abstract
BACKGROUND AND OBJECTIVES There is little consensus on how multimorbidity should be operationalized in life course research. We set out to derive better empirical definitions for multimorbidity by examining its different operationalizations and their associations with mortality, functional independence and physical capability in a longitudinal population-representative cohort.
RESEARCH DESIGN AND METHODS We used data from 2653 (51.6% female) study members in the MRC National Survey of Health and Development (NSHD), a British cohort born in 1946. We examined predictive utility of five multimorbidity operationalizations by age 63 (binary multimorbidity, unweighted disease count, weighted disease count, clustered multimorbidity, cumulative multimorbidity) using 16 chronic disease, to predict 12-year mortality and age 69 functional independence and physical capability (grip strength, chair rise speed, balance).
RESULTS The multimorbidity operationalizations of unweighted disease count (16.3%) and weighted disease count (16.7%) explained the highest variation for mortality compared with other operationalizations. Similarly, explained variation for unweighted disease count (17.0%) and weighted disease count (16.4%) showed the highest prediction for functional independence and physical capability at age 69 years, with minor variations in physical performance measures where clustered multimorbidity also explained high variance (e.g. 8.6% for changes in chair rise speed). Binary multimorbidity, although frequently used in research was the least predictive of all outcomes.
DISCUSSION AND IMPLICATIONS The associations between various multimorbidity measures and mortality and physical functioning lend support to important influence of multimorbidity on later-life health and functioning while highlighting the differences in variance prediction and point estimates when different approaches to operationalizing multimorbidity are used. An unweighted disease count approach might be suitable for many epidemiological research questions as it is simple to estimate while being as predictive as other more complex approaches such as weighted disease counts.
Translational Significance Multimorbidity research urgently needs a standardized approach to its measurement and operationalization. This study simultaneously compares different strengths of association between multimorbidity definitions and mortality, functional independence and physical capability. This adds possibility by using the predictive utility for mortality, functional independence and physical capability as criteria for determining the usefulness of a given operationalization. Quantifying how these vary offers practical choices between methods of operationalizing multimorbidity for various purposes in research and clinical settings, for example, a targeted strategy aimed at understanding mortality, physical function and health care utilization.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the following grants: This work was supported by the UK Medical Research Council which provides core funding for the Medical Research Council Unit for Lifelong Health and Ageing at University College London and the Medical Research Council National Survey of Health and Development (grant numbers MC_UU_00019/1, MC_UU_00019/3). Han Sang Seo was supported by grant from Medical Research Council (grant number MC_UU_00019/3).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The 1946 MRC National Survey of Health & Development (NSHD) data is available for research via application to the NSHD Data Sharing Committee, a data sharing agreement being in place between UCL and the academic institution that employs the researcher, and LHA resources being available to meet the requests for data sharing. Additionally, all proposals to use the NSHD data must support and adhere to the core principles of data sharing with the Medical Research Council (MRC).
For more information on the NSHD, access to data & collaborations, please see http://www.nshd.mrc.ac.uk/data/data-sharing or contact mrclha.enquiries{at}ucl.ac.uk
Further information can also be accessed at: https://skylark.ucl.ac.uk
